TPH1 inhibits bladder tumorigenesis by targeting HIF-1α pathway in bladder cancer.

Taken together, these results suggested that increasing TPH1 activity could inhibit survival and proliferation of cells via HIF-1α pathway. TPH1 may be a potential target for human BCa therapy.